» Articles » PMID: 25369881

Doping in Sport: Effects, Harm and Misconceptions

Overview
Journal Intern Med J
Specialty General Medicine
Date 2014 Nov 6
PMID 25369881
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Doping in sport is a widespread problem not just among elite athletes, but even more so in recreational sports. In scientific literature, major emphasis is placed on doping detection, whereas detrimental effects of doping agents on athletes' health are seldom discussed. Androgenic anabolic steroids are well known for their positive effects on muscle mass and strength. Human growth hormone also increases muscle mass, although the majority of that is an increase in extracellular fluid and not the functional muscle mass. In recreational athletes, growth hormone does not have major effect on muscle strength, power or aerobic capacity, but stimulates anaerobic exercise capacity. Erythropoietin administration increases oxygen-carrying capacity of blood improving endurance measures, whereas systemic administration of beta-adrenergic agonists may have positive effect on sprint capacity, and beta-adrenergic antagonists reduce muscle tremor. Thus, there are certain drugs that can improve selective aspects of physical performance. However, most of the doping agents exert serious side-effects, especially when used in combination, at high doses and for a long duration. The extent of long-term health consequences is difficult to predict, but likely to be substantial, especially when gene doping is considered. This review summarises the main groups of doping agents used by athletes, with the main focus on their effects on athletic performance and adverse effects.

Citing Articles

Perceived motivational climate, doping attitudes, and doping temptation among elite adolescent athletes: The moderating role of perfectionism.

Kristensen J, Kavussanu M, Ommundsen Y Eur J Sport Sci. 2025; 25(3):e12244.

PMID: 39960831 PMC: 11832028. DOI: 10.1002/ejsc.12244.


Doping in elite cycling: a qualitative study of the underlying situations of vulnerability.

Filleul V, dArripe-Longueville F, Pavot D, Bimes H, Maillot J, Meinadier E Front Sports Act Living. 2024; 6:1482103.

PMID: 39650252 PMC: 11620872. DOI: 10.3389/fspor.2024.1482103.


Safety Implications of Off-Label Medication Use in Athletes: A Narrative Review.

Silva V, Madeira R, Joaquim J, Matos C Medicines (Basel). 2024; 11(8).

PMID: 39584970 PMC: 11627157. DOI: 10.3390/medicines11080020.


Development of Reference Point of Doping Attitude and Dispositions for Anti-Doping Education Notification of Athletes: Application of Reference Group Model.

Jeon M, Oh H, Lim H, Yun H Iran J Public Health. 2024; 53(2):348-355.

PMID: 38894835 PMC: 11182474. DOI: 10.18502/ijph.v53i2.14919.


Exploring the scope and applications of anti-doping measures in ultramarathon: an analysis of the positions of ultramarathon race organizers.

Colangelo J, Smith A, Hachen S, Liebrenz M Front Sports Act Living. 2024; 6:1406638.

PMID: 38840955 PMC: 11150625. DOI: 10.3389/fspor.2024.1406638.